Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
published in: Frontiers in Immunology
date of publication: 2021-02-02
language: English
main subject: rituximab
Cites articles
There is nothing here
Article - wd:Q110597672